Trial Profile
Defining a novel law of glucose homeostasis under Dapagliflozin usage by mathematical model approach
Status:
Not yet recruiting
Phase of Trial:
Phase I
Latest Information Update: 21 Aug 2017
Price :
$35
*
At a glance
- Drugs Dapagliflozin (Primary)
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- 15 Aug 2017 Planned initiation date changed from 1 Sep 2016 to 8 Dec 2016.
- 16 Sep 2016 New trial record